Aditxt (ADTX) had the highest return in Q3 2023 by a US stock, returning 2,675.6%.

ASSET	QUARTER	% RETURN
Aditxt (ADTX)	Q3 2023	2,675.56%
Urgently Inc Common Stock (ULY)	Q3 2023	874.39%
Renovaro Biosciences (RENB)	Q3 2023	718.38%
Soleno Therapeutics (SLNO)	Q3 2023	604.3%
error (ZVZZT)	Q3 2023	556.39%
Femasys (FEMY)	Q3 2023	441.82%
Taysha Gene Therapies (TSHA)	Q3 2023	371.64%
Farmmi (FAMI)	Q3 2023	294.29%
Antelope Enterprise (AEHL)	Q3 2023	260.55%
Safety Shot (SHOT)	Q3 2023	247.67%
Tango Therapeutics (TNGX)	Q3 2023	241.21%
Oncology Institute (TOIIW)	Q3 2023	229.39%
Abpro (ABPWW)	Q3 2023	210.08%
Akso Health Group ADR (AHG)	Q3 2023	204.76%
SHF (SHFSW)	Q3 2023	195.12%
VistaGen Therapeutics (VTGN)	Q3 2023	186.34%
Foxx Development (FOXXW)	Q3 2023	176%
Cardlytics (CDLX)	Q3 2023	160.66%
Groupon (GRPN)	Q3 2023	160.54%
Armata Pharmaceuticals (ARMP)	Q3 2023	158.62%
GeneDx (WGSWW)	Q3 2023	155.56%
Performance Shipping (PSHG)	Q3 2023	149.37%
Helport AI Limited Warrants (HPAIW)	Q3 2023	147.6%
Universe Pharmaceuticals (UPC)	Q3 2023	147.4%
United States Cellular (USM)	Q3 2023	145.12%